www.fdanews.com/articles/149466-more-good-news-from-medtronic-rsquo-s-symplicity-high-blood-pressure-trial

More Good News From Medtronic’s Symplicity High Blood Pressure Trial

September 14, 2012

An analysis of data from Medtronic’s Symplicity HTN 2 renal denervation trial showed that the procedure is a cost-effective way to treat resistant hypertension, or high blood pressure.
Mass Device